Janssen News
Most Popular Janssen Story
Vertex aims to sell telaprevir milestone payments
Vertex Pharmaceuticals has decided to sell the rights to future milestone payments for the development and marketing of its hepatitis C drug telaprevir. While Vertex has retained the North American Read more...
Latest Headlines
- January 10, 2012
- December 19, 2011
- December 9, 2011
- August 26, 2011
- August 6, 2010
- August 17, 2009
- July 10, 2009
- October 20, 2008
- October 24, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
